Chakraborty Subhanil, Roy Babli, Sen Subhajit, Mandal Santi M, Das Arghya, Chakraborty Ranadhir
Omics Laboratory, Department of Biotechnology University of North Bengal, Raja Rammohunpur, P.O. NBU, Darjeeling, West Bengal 734013, India.
Department of Chemistry Tufanganj Mahavidyalaya, P.O. Tufanganj, New Town, Coochbehar, West Bengal 736160, India.
J Pathog. 2024 Sep 30;2024:1997064. doi: 10.1155/2024/1997064. eCollection 2024.
The involvement of multiple antibiotic-resistant gastrointestinal pathogens in diarrhea aggravates the disease condition uncontrollably. The current study aimed to find and develop a suitable formulation utilizing multiple natural components from known plant sources to augment the current therapeutic outcomes. The hydroethanolic extraction method was applied through boiling and fermentation on ancient observation-based efficacious plant parts for developing the antidiarrheal polyherbal formulation AP-01. An animal study model of diarrhea was used to evaluate the safety and efficacy of the formulation. The formulation was tested on four different multiple antibiotic-resistant gastrointestinal pathogens collected from the national repository. The formulation depicted no cytotoxicity on normal gut cells and was efficacious at 10 ml/kg single dose in relieving symptoms of diarrhea by 79.71%, compared with the standard drug showing a reduction of symptoms by 83.01%. AP-01 exhibited delayed gastric motility. The symptoms of diarrhea ceased to occur within 320.66 ± 5.05 minutes with AP-01, whereas the standard drug took 308 ± 6.63 minutes. AP-01 was found successful at a viable dosage regimen of 75 l/ml v/v to 100 l/ml v/v in inhibiting the growth of different pathogens from the Enterobacteriaceae family possessing resistance against several classes of antibiotics in culture media. Chemical analysis revealed different alkaloids, flavonoids, and polyphenols that probably work in unison through multiple modes of action to arrest diarrhea and inhibit pathogens simultaneously. These promising results shown by AP-01 should evoke an effort to dive deep into research and development for better therapeutic formulations for infectious diarrhea by harvesting nature's arsenal.
多种耐抗生素的胃肠道病原体参与腹泻会使病情不可控制地恶化。当前的研究旨在寻找并开发一种合适的制剂,利用已知植物来源的多种天然成分来提高当前的治疗效果。采用水乙醇提取法,通过对基于古代观察有效的植物部位进行煮沸和发酵,来研制止泻复方草药制剂AP - 01。使用腹泻动物研究模型来评估该制剂的安全性和有效性。该制剂在从国家储存库收集的四种不同的多重耐抗生素胃肠道病原体上进行了测试。该制剂对正常肠道细胞无细胞毒性,单剂量10 ml/kg时可有效缓解腹泻症状,缓解率为79.71%,而标准药物的症状缓解率为83.01%。AP - 01表现出胃动力延迟。使用AP - 01时,腹泻症状在320.66±5.05分钟内停止出现,而标准药物则需要308±6.63分钟。发现在75 l/ml v/v至100 l/ml v/v的有效剂量方案下,AP - 01能够抑制来自肠杆菌科不同病原体在培养基中的生长,这些病原体对几类抗生素具有抗性。化学分析揭示了不同的生物碱、黄酮类化合物和多酚类物质,它们可能通过多种作用模式协同发挥作用,同时阻止腹泻并抑制病原体。AP - 01所显示的这些有前景的结果应该促使人们努力深入开展研发工作,通过利用大自然的宝库来开发更好的感染性腹泻治疗制剂。